2-(substituted-phenyl)amino-imidazoline derivatives

US6596876B2 · kind B2 · utility

Assignee

• Syntex (U.S.A.) LLC · US

Inventors

• Keith R. Bley · Menlo Park, US
• Robin Clark · Palo Alto, US
• Alam Jahangir · San Jose, US
• Bruce Andrew Kowalczyk · Cupertino, US
• Francisco Javier Lopez-Tapia · Mahwah, US
• Alexander Victor Muehldorf · Sunnyvale, US
• Counde O'Yang · Sunnyvale, US
• Thomas Sun · Fremont, US

Key dates

• Filing date: May 31, 2002
• Grant date: Jul 22, 2003
• Expiry date: May 31, 2022

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/10
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where:R1 is a group represented by formula (A), (B) or (C);  and other substituents as defined in the specification, and their pharmaceutically acceptable salts or crystal forms thereof; and pharmaceutical compositions containing them; and methods and their use as therapeutic agents.